title: Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response.
authors.affiliation: Clinica Malattie Infettive, DIPMI, DISSAL, IRCCS San Martino-IST, Università di Genova, Genova, Italy. Electronic address: daniele.roberto.giacobbe@gmail.com.
authors.forename: D R
authors.initials: DR
authors.lastname: Giacobbe
authors.affiliation: Clinica Malattie Infettive, DIPMI, DISSAL, IRCCS San Martino-IST, Università di Genova, Genova, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Viscoli
authors.affiliation: Clinica Malattie Infettive, DIPMI, DISSAL, IRCCS San Martino-IST, Università di Genova, Genova, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Furfaro
authors.affiliation: Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
authors.forename: A L
authors.initials: AL
authors.lastname: Colombo
authors.affiliation: Clinica Malattie Infettive, DIPMI, DISSAL, IRCCS San Martino-IST, Università di Genova, Genova, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Del Bono
mesh_terms: D058387:Candidemia / Q000175:diagnosis* / Q000401:mortality* / Q000473:pathology; D006801:Humans; D011379:Prognosis; D011509:Proteoglycans; D044967:Serum / Q000737:chemistry*; D016019:Survival Analysis; D047071:beta-Glucans / Q000097:blood*
chemical_list: D011509:Proteoglycans; D047071:beta-Glucans; C010770:polysaccharide-K